< >
SC psychedelic clinical trials
Inside the NHS: Psilocybin-Assisted Therapy Enters the Public Healthcare System
A landmark NHS trial shows a single 25-mg dose of psilocybin, paired with structured psychological support, produces a large and sustained reduction in treatment-resistant depression—proving the model can work inside conventional public health infrastructure, not just boutique clinics.
6 min · 4 researchers · 10 concepts